Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who …
Read More
PHILADELPHIA, PA — With the novel coronavirus spreading widely in PA, advocacy group PennPIRG released a scorecard that gives PA an F for not doing enough COVID-19 testing. Health experts …
Read More
IMMACULATA UNIVERSITY, PA — Immaculata University now offers two new athletic training program options. The accelerated 3+2 track, provides students an option to complete an accelerated bachelor’s degree matriculating into the …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced positive preliminary topline results from a 12-week, Phase …
Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) continues to deliver complete confidence with the release of the Arrow® ErgoPack® Complete Multi-Lumen Access Catheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) …
Read More
MALVERN, PA — The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech …
Read More
WEST READING, PA — Tower Health Transplant Institute (THTI) performed its first liver transplant at Reading Hospital on Thursday, December 3. The surgery was performed by Tower Health transplant surgeons …
Read More
WASHINGTON, D.C. — The U.S. Department of Veterans Affairs (VA) announced it is partnering with the American Lung Association to help Veterans, diagnosed with lung disease, live healthier lives.
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
Read More